Search research articles
Contact Us
Filters
Showing results (131-140 of 177) with videos related to
Page
of 18
Sort By:
American Heart Journal
|
December 16, 2023
Study of heart function in PRE-Eclampsia during and after PreGnancy (SHePREG): The pilot cohort
Marwan Ma'ayeh, Omer Cavus, Lauren J Hassen, et al.
Clinical Pharmacokinetics
|
June 10, 2011
Structural models describing placebo treatment effects in schizophrenia and other neuropsychiatric disorders
Venkatesh Pilla Reddy, Magdalena Kozielska, Martin Johnson, et al.
Schizophrenia Research
|
February 26, 2013
Sensitivity of individual items of the Positive and Negative Syndrome Scale (PANSS) and items subgroups to differentiate between placebo and drug treatment in schizophrenia
Magdalena Kozielska, Venkatesh Pilla Reddy, Martin Johnson, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
March 4, 2019
The right ventricular response to lung resection
Philip J McCall, Alex Arthur, Adam Glass, et al.
Pharmacology Research & Perspectives
|
June 23, 2020
A multicenter, phase I, pharmacokinetic study of osimertinib in cancer patients with normal renal function or severe renal impairment
Karthick Vishwanathan, Inmaculada Sanchez-Simon, Bhumsuk Keam, et al.
Pharmaceutical Research
|
March 23, 2012
Pharmacokinetic-pharmacodynamic modeling of the D₂ and 5-HT (2A) receptor occupancy of risperidone and paliperidone in rats
Magdalena Kozielska, Martin Johnson, Venkatesh Pilla Reddy, et al.
Echo Research and Practice
|
June 7, 2026
Significance of echocardiographic metrics including TRV and TAPSE/SPAP in mild haemodynamic pulmonary hypertension - data from EVIDENCE-PAH UK
Nina Karia, Daniel Murphy, Luke Howard, et al.
Oncogene
|
August 8, 2018
Induction of store-operated calcium entry (SOCE) suppresses glioblastoma growth by inhibiting the Hippo pathway transcriptional coactivators YAP/TAZ
Zhijun Liu, Yiju Wei, Lei Zhang, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 16, 2019
Pharmacokinetic Study of Osimertinib in Cancer Patients with Mild or Moderate Hepatic Impairment
Enrique Grande, R Donald Harvey, Benoit You, et al.
Pharmaceutical Research
|
June 8, 2011
Mechanism-based pharmacokinetic-pharmacodynamic modeling of the dopamine D2 receptor occupancy of olanzapine in rats
Martin Johnson, Magdalena Kozielska, Venkatesh Pilla Reddy, et al.
Page
of 18
Search research articles
Search
Showing results (131-140 of 177) with videos related to
Sort By:
Page
of 18
American Heart Journal
|
December 16, 2023
Study of heart function in PRE-Eclampsia during and after PreGnancy (SHePREG): The pilot cohort
Marwan Ma'ayeh, Omer Cavus, Lauren J Hassen, et al.
Clinical Pharmacokinetics
|
June 10, 2011
Structural models describing placebo treatment effects in schizophrenia and other neuropsychiatric disorders
Venkatesh Pilla Reddy, Magdalena Kozielska, Martin Johnson, et al.
Schizophrenia Research
|
February 26, 2013
Sensitivity of individual items of the Positive and Negative Syndrome Scale (PANSS) and items subgroups to differentiate between placebo and drug treatment in schizophrenia
Magdalena Kozielska, Venkatesh Pilla Reddy, Martin Johnson, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
March 4, 2019
The right ventricular response to lung resection
Philip J McCall, Alex Arthur, Adam Glass, et al.
Pharmacology Research & Perspectives
|
June 23, 2020
A multicenter, phase I, pharmacokinetic study of osimertinib in cancer patients with normal renal function or severe renal impairment
Karthick Vishwanathan, Inmaculada Sanchez-Simon, Bhumsuk Keam, et al.
Pharmaceutical Research
|
March 23, 2012
Pharmacokinetic-pharmacodynamic modeling of the D₂ and 5-HT (2A) receptor occupancy of risperidone and paliperidone in rats
Magdalena Kozielska, Martin Johnson, Venkatesh Pilla Reddy, et al.
Echo Research and Practice
|
June 7, 2026
Significance of echocardiographic metrics including TRV and TAPSE/SPAP in mild haemodynamic pulmonary hypertension - data from EVIDENCE-PAH UK
Nina Karia, Daniel Murphy, Luke Howard, et al.
Oncogene
|
August 8, 2018
Induction of store-operated calcium entry (SOCE) suppresses glioblastoma growth by inhibiting the Hippo pathway transcriptional coactivators YAP/TAZ
Zhijun Liu, Yiju Wei, Lei Zhang, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 16, 2019
Pharmacokinetic Study of Osimertinib in Cancer Patients with Mild or Moderate Hepatic Impairment
Enrique Grande, R Donald Harvey, Benoit You, et al.
Pharmaceutical Research
|
June 8, 2011
Mechanism-based pharmacokinetic-pharmacodynamic modeling of the dopamine D2 receptor occupancy of olanzapine in rats
Martin Johnson, Magdalena Kozielska, Venkatesh Pilla Reddy, et al.
Page
of 18